Cargando…

THE SPASTICITY-RELATED QUALITY OF LIFE 6-DIMENSIONS INSTRUMENT IN UPPER-LIMB SPASTICITY: PART II A FIRST PSYCHOMETRIC EVALUATION

OBJECTIVE: Psychometric evaluation of the Spasticity- related Quality of Life 6-Dimensions instrument (SQoL-6D). DESIGN: A clinimetric evaluation conducted in a multicentre, prospective, longitudinal cohort study at 8 UK sites. PATIENTS: Adult patients (n = 104) undergoing focal treatment of upper-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	TURNER-STOKES, Lynne, FHEODOROFF, Klemens, JACINTO, Jorge, LAMBERT, Jeremy, DE LA LOGE, Christine, CALVI-GRIES, Françoise, WHALEN, John, LYSANDROPOULOS, Andreas, MAISONOBE, Pascal, ASHFORD, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Foundation for Rehabilitation Information 2021
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862650/ https://www.ncbi.nlm.nih.gov/pubmed/34726764 http://dx.doi.org/10.2340/jrm.v53.688

Ejemplares similares

THE SPASTICITY-RELATED QUALITY OF LIFE 6-DIMENSIONS INSTRUMENT IN UPPER-LIMB SPASTICITY: PART I DEVELOPMENT AND RESPONSIVENESS
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

LONGITUDINAL GOAL ATTAINMENT WITH INTEGRATED UPPER LIMB SPASTICITY MANAGEMENT INCLUDING REPEAT INJECTIONS OF BOTULINUM TOXIN A: FINDINGS FROM THE PROSPECTIVE, OBSERVATIONAL UPPER LIMB INTERNATIONAL SPASTICITY (ULIS-III) COHORT STUDY
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

ASSESSING THE EFFECTIVENESS OF UPPER-LIMB SPASTICITY MANAGEMENT USING A STRUCTURED APPROACH TO GOAL-SETTING AND OUTCOME MEASUREMENT: FIRST CYCLE RESULTS FROM THE ULIS-III STUDY
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study
por: Fheodoroff, Klemens, et al.
Publicado: (2015)

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
por: Turner-Stokes, Lynne, et al.
Publicado: (2016)

Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management
por: Turner-Stokes, Lynne, et al.
Publicado: (2013)

Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice
por: Turner-Stokes, Lynne, et al.
Publicado: (2013)

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study
por: Jacinto, Jorge, et al.
Publicado: (2022)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020)

Psychometric properties of measures of upper limb activity performance in adults with and without spasticity undergoing neurorehabilitation–A systematic review
por: Pike, Shannon, et al.
Publicado: (2021)

CLINICAL PRESENTATION OF PATIENTS WITH LOWER LIMB SPASTICITY UNDER-GOING ROUTINE TREATMENT WITH BOTULINUM TOXIN: BASELINE FINDINGS FROM AN INTERNATIONAL OBSERVATIONAL STUDY
por: ESQUENAZI, Alberto, et al.
Publicado: (2023)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020)

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

MODELLING LONG-TERM OUTCOMES AND RISK OF DEATH FOR PATIENTS WITH POST-STROKE SPASTICITY RECEIVING ABOBOTULINUMTOXINA TREATMENT AND REHABILITATION THERAPY
por: FHEODOROFF, Klemens, et al.
Publicado: (2022)

A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity
por: Bezzina, Clive, et al.
Publicado: (2023)

Difficult conditions of the spastic upper limb
por: Bhardwaj, Praveen
Publicado: (2015)

Composite active range of motion (CX(A)) and relationship with active function in upper and lower limb spastic paresis
por: Bayle, Nicolas, et al.
Publicado: (2020)

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
por: Kong, Keng He, et al.
Publicado: (2017)

The role of neurectomy in the management of spasticity of the upper limb
por: Mikalef, Petros, et al.
Publicado: (2017)

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019)

AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
por: Esquenazi, Alberto, et al.
Publicado: (2021)

Upper limb impairments associated with spasticity in neurological disorders
por: Tsao, Cheng-Chi, et al.
Publicado: (2007)

Balneotherapy in Treatment of Spastic Upper Limb after Stroke
por: Erceg-Rukavina, Tatjana, et al.
Publicado: (2015)

Initial psychometric validation of the questionnaire on pain caused by spasticity (QPS)
por: Geister, Thorin L., et al.
Publicado: (2017)

Psychometric properties of trunk impairment scale in children with spastic diplegia
por: Dasoju, Vedasri, et al.
Publicado: (2021)

Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018)

Spastic Constipation
Publicado: (1906)

The Spastic Colon
por: Smith, David
Publicado: (1936)

Outcome of selective motor fasciculotomy in the treatment of upper limb spasticity
por: Puligopu, Aneel Kumar, et al.
Publicado: (2011)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

Effect of post-stroke spasticity on voluntary movement of the upper limb
por: Lackritz, Hadar, et al.
Publicado: (2021)

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay without Spasticity
por: Aida, Izumi, et al.
Publicado: (2021)

Improving the Management of Post-Stroke Spasticity: Time for Action
por: Christofi, Gerry, et al.
Publicado: (2018)

Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
por: Gracies, Jean-Michel, et al.
Publicado: (2021)

Author Correction: Psychometric properties of trunk impairment scale in children with spastic diplegia
por: Dasoju, Vedasri, et al.
Publicado: (2021)

WORLDWIDE SURVEY OF CLINICIAN PRACTICE ON USE OF ADJUNCTIVE THERAPIES FOLLOWING BOTULINUM TOXIN INJECTION FOR SPASTICITY
por: SCHILLEBEECKX, Fabienne, et al.
Publicado: (2022)

Orthopaedic surgery in spasticity
por: Frost, Harold M., 1921-
Publicado: (1972)

Spasticity Mechanisms – for the Clinician
por: Mukherjee, Angshuman, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6nh68thcdfnsa4t8fb68vd39rf